GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Itonis Inc (OTCPK:ITNS) » Definitions » Capex-to-Revenue

Itonis (Itonis) Capex-to-Revenue : 0.00 (As of Feb. 2008)


View and export this data going back to 2007. Start your Free Trial

What is Itonis Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Itonis's Capital Expenditure for the three months ended in Feb. 2008 was $0.00 Mil. Its Revenue for the three months ended in Feb. 2008 was $0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.


Itonis Capex-to-Revenue Historical Data

The historical data trend for Itonis's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Itonis Capex-to-Revenue Chart

Itonis Annual Data
Trend Nov05 Nov06 Nov07
Capex-to-Revenue
- 1.38 0.20

Itonis Quarterly Data
Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 - -0.61 1.14 -

Competitive Comparison of Itonis's Capex-to-Revenue

For the Medical Distribution subindustry, Itonis's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Itonis's Capex-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Itonis's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Itonis's Capex-to-Revenue falls into.



Itonis Capex-to-Revenue Calculation

Itonis's Capex-to-Revenue for the fiscal year that ended in Nov. 2007 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.042) / 0.207
=0.20

Itonis's Capex-to-Revenue for the quarter that ended in Feb. 2008 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Itonis  (OTCPK:ITNS) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Itonis Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Itonis's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Itonis (Itonis) Business Description

Traded in Other Exchanges
N/A
Address
22600-C Lambert Street, Suite 902, Lake Forest, CA, USA, 92630
Itonis Inc is a development-stage company. It operates as a holding company, which engages in the development and distribution of products to the medical and pharmaceutical industry. It is presently focused on marketing its Emesyl homeopathic anti-nausea product for retail sale. It produces and markets over-the-counter and prescription homeopathic preparations to treat both common ailments and chronic diseases.

Itonis (Itonis) Headlines